Germs that produce the extended spectrum betalactamases;Les germes producteurs de beta lactamases a spectre etendu: Epidemie dans un service d'hemato-oncologie

Tunisie Medicale

Volumn 82, Issue 11, 2004, Pages 1006-1011

  Mahmal, Lahoucine ^b   Loukili, Asmaa ^a   Harif, Mhamed ^a   Quessar, Asmaa ^a   Benbachir, Mohamed ^a   Benchekroun, Said ^a  

^a IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^b CHU Mohammed VI   (Morocco)

Author keywords

Extended; Lactamases; Spectrum B

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; AZTREONAM; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NEOMYCIN; NETILMICIN; PENICILLIN DERIVATIVE; ANTIINFECTIVE AGENT;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; ENTEROBACTERIACEAE; FEMALE; HODGKIN DISEASE; HUMAN; INFECTION; MALE; NEUTROPENIA; NONHUMAN; RETROSPECTIVE STUDY; ACUTE DISEASE; BIOSYNTHESIS; COMPARATIVE STUDY; CROSS INFECTION; EMERGENCY; ENTEROBACTER INFECTION; ENZYMOLOGY; ESCHERICHIA COLI; LEUKEMIA; MICROBIOLOGY; MOROCCO; MORTALITY; NONHODGKIN LYMPHOMA; SEPTIC SHOCK; TIME; UNIVERSITY HOSPITAL;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORINS; CROSS INFECTION; EMERGENCIES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; IMIPENEM; LEUKEMIA; LYMPHOMA, NON-HODGKIN; MALE; MOROCCO; NEUTROPENIA; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; TIME FACTORS;

EID: 14644438533     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. LEROY O, BEAUCAIRE G. Lutte contre la diffusion des infections 6 entérobactéries sécrétrices de běto- lactamases à spectre étendu. Méd Mal Infect 1996; 26: 609-7.
2. Normann P, Naas T, Labia R. Les nouvelles bětaladamoses des bacilles à Gram négatif. Lettre Infectiologue 1994; IX: 151-4.
3. Sirot D. Běta-lactamases plasmidiques à spectre étendu. J Antimicrob Chemother 1995; 36, Suppl A: 19-34.
4. Sanders CC, Sanders WE Jr. B-Lactam resistance in Gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992; 15: 824-39.
5. Soilleux MJ. Survey of Klebsiella pneumoniae producing extended-spectrum B-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France. Antimicrob Agents Chemother 1996; 40: 1027-9.
6. Livermore DM. Bětalaciamases: distribution et inhibition. Lettre Infectiologue 1992, numéro hors série.
7. Rice LB, Willey SH, Papanicolaou GA et al. Outbreak of ceftazidim resistance caused by extended-spectrum B-lactamase at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990; 34: 2193-9.
8. Naumovskil Quinn et al. Outbreak of ceftazldim resistance due ta novel extended-spectrum B-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 1992; 36: 1991-6.
9. Arstila T, Auvinen H, Huovinen P and the Finnish group for antimicrobial resistance. Beta-lactam resistance among Escherichia coli and Klebsiella species blood culture isolates in Finnish hospitals. Eur J Clin Microb Infect Dis 1994; 13: 468-74.
10. Garroussete MT, Marie O et al. Oropharyngeal and digestive colonization by multiresistant Gram-negative bacilli in ICU patients: a risk of bacteriologically related nosocomial infection. In Program and Abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstr n°998, 1991, American Society for Microbiology, Washington DC.
11. Garroussete M, Schlemmer B. Relation entre colonisation bactérienne et infection acquise en réanimation. In: « L'infection acquise en réanimation ». Perspectives en Réanimation. Société de réanimation de langue Française, Arnette et Blackwel Eds, 1995: 149-62.
12. Lucet JC, Chevret S et al. Risk factors for acquiring extended-spectrum B-lactamases enterobacteriaceae in ICU patients. In program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstr n°637, 1992, American Society for Microbiology, Washington DC.